In light of the ongoing COVID19 pandemic the CCHS Network/Foundation has decided to postpone the 2020 grant cycle. For more information or questions, contact RAB Chair, Dr. Eddy Yang, M.D., Ph.D.
The Congenital Central Hypoventilation Syndrome (CCHS) grant award represents a collaborative effort between the CCHS Network and the CCHS Foundation to encourage and support basic, clinical, translational, or epidemiological research to impact the lives of patients with CCHS.
Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in a related field and have a faculty appointment or equivalent with demonstrated institutional commitment to the Principal Investigator (research lab space, clinical studies support, etc). Junior faculty, post-doctoral fellows and residents are also eligible, provided a mentoring team is designated with strong letter of support.
Focus areas include investigations related to the CCHS young adult population, development of innovative technology or treatment modalities, and basic/translational research in CCHS biology. Inquiries are encouraged to vet clinical and translational research proposal with the CCHS Network.
Applications are peer-reviewed by the CCHS Research Advisory Board (RAB) comprised of researchers and physicians respected for their accomplishments and expertise in the care of CCHS patients and the biology of CCHS. Also on the RAB are parents and family members of CCHS patients who are have a medical or scientific background.
The following review criteria will be used when reviewing applications and determining funding decisions:
For application information, policies and procedures, and general information, please email the RAB Chair at email@example.com.